TY - JOUR
T1 - Comparison of the rodac imprint method to selective enrichment broth for recovery of vancomycin-resistant enterococci and drug-resistant enterobacteriaceae from environmental surfaces
AU - Hacek, D. M.
AU - Trick, W. E.
AU - Collins, S. M.
AU - Noskin, G. A.
AU - Peterson, L. R.
PY - 2000
Y1 - 2000
N2 - We compared the Rodac imprint technique to selective enrichment broth for detecting vancomycin-resistant enterococci (VRE) and multidrug-resistant Enterobacteriaceae (MDRE) on surfaces. Rodac plates contained tryptic soy agar with 5% sheep blood, vancomycin (6 μg/ml), ceftazidime (2 μg/ml), amphotericin B (2 μg/ml), and clindamycin (1 μg/ml). Two types of broth were used: brain heart infusion (BHI) and BHI plus vancomycin (6 μg/ml) and ceftazidime (2 μg/ml) (BHIVC). Of the 46 surfaces cultured for VRE, 12 (26%) were positive. Of the 12 VRE-positive surfaces, 11 (92%) grew from Rodac, 8 (67%) grew from BHIVC, and 7 (58%) grew from BHI. A larger study is needed for MDRE, as only 4 of 43 surfaces were MDRE positive. The Rodac imprint technique successfully recovered VRE from environmental surfaces.
AB - We compared the Rodac imprint technique to selective enrichment broth for detecting vancomycin-resistant enterococci (VRE) and multidrug-resistant Enterobacteriaceae (MDRE) on surfaces. Rodac plates contained tryptic soy agar with 5% sheep blood, vancomycin (6 μg/ml), ceftazidime (2 μg/ml), amphotericin B (2 μg/ml), and clindamycin (1 μg/ml). Two types of broth were used: brain heart infusion (BHI) and BHI plus vancomycin (6 μg/ml) and ceftazidime (2 μg/ml) (BHIVC). Of the 46 surfaces cultured for VRE, 12 (26%) were positive. Of the 12 VRE-positive surfaces, 11 (92%) grew from Rodac, 8 (67%) grew from BHIVC, and 7 (58%) grew from BHI. A larger study is needed for MDRE, as only 4 of 43 surfaces were MDRE positive. The Rodac imprint technique successfully recovered VRE from environmental surfaces.
UR - http://www.scopus.com/inward/record.url?scp=0034462901&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034462901&partnerID=8YFLogxK
U2 - 10.1128/jcm.38.12.4646-4648.2000
DO - 10.1128/jcm.38.12.4646-4648.2000
M3 - Article
C2 - 11101613
AN - SCOPUS:0034462901
SN - 0095-1137
VL - 38
SP - 4646
EP - 4648
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
IS - 12
ER -